Ledger.Open graph →
SEC Form D · Amendment · filed March 22, 2019

Alvarado Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Christopher A. Kroeger · Marlborough, MAExec · DirectorRobert A. Malenka · San Francisco, CADirectorJames A. Lillie · San Francisco, CAExecJonathan A. Gillis · San Francisco, CAExecGeorge A. Pavlov · San Francisco, CADirectorPeter A. Bisgaard · Lexington, MADirectorChristopher A. Kroeger · San Francisco, CAExec · DirectorRobert A. Malenka · San Francisco, CADirectorJames A. Lillie · San Francisco, CAExecGeorge A. Pavlov · San Francisco, CADirectorPeter A. Bisgaard · Lexington, MADirectorJonathan A. Gillis · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗